Converge Bio: Funding, Investors & Team (Oct 2026)
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
Converge Bio has raised $30.5M across 2 funding rounds on record, the most recent a Series A of $25.0M announced in Jan 2026.
That round is above the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Converge Bio Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Converge Bio Funding Rounds
Converge Bio raised $5.5M in a Seed announced in Nov 2024.
1.2 years later, a Series A of $25.0M was announced in Jan 2026.
Converge Bio Founders and Leadership Team
Contact details for the Converge Bio team: 2 of 2 have an email address on file.
Start 14-day free trial →Converge Bio Funding Compared to Other Artificial Intelligence Startups
Converge Bio's latest round of $25.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Converge Bio in Artificial Intelligence and Wilmington
Companies Similar to Converge Bio
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Nyne is the people data company. We deploy tens of millions of autonomous agents across the open web to…
Vinci utilizes generative artificial intelligence to create hardware design. Its services cover the design,…
Siena AI is an innovative customer service platform designed specifically for commerce. It combines the…
Factory is a developer of an AI-based platform for computer codes and software engineering. Its platform…
Ocular is a Cloud and Artificial Intelligence company, backed by Y Combinator, bringing Enterprise AI and…
Ghost is a consumer hardware and software company building a private, local-first computing system for…
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial…
The EnCharge AI platform provides a reliable computing solution that enables the utilization of highly…
The hardest unsolved problem in robotics isn't perception or locomotion, it's dexterity. Tangent Robotics…
Autopoiesis Sciences creates advanced AI models that aim to enable groundbreaking scientific advancements…
Converge Bio Funding FAQs
What does Converge Bio do?
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
How much funding has Converge Bio raised?
Converge Bio has raised $30.5M across 2 rounds on record. The most recent is a Series A of $25.0M announced in Jan 2026.
When did Converge Bio last raise funding?
Converge Bio's most recent funding round on record is a Series A of $25.0M, announced in Jan 2026.
Who founded Converge Bio?
FundedIQ lists Dov Gertz (Founder), Oded Kalev (Founder) at Converge Bio.
Where is Converge Bio headquartered?
Converge Bio is based in Wilmington, Delaware, United States.
How many employees does Converge Bio have?
Converge Bio is in the 11-50 employee band.
How does Converge Bio's funding compare to other Artificial Intelligence startups?
Converge Bio's latest round of $25.0M is above the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,241 tracked companies over the last two years.
About FundedIQ's Converge Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Converge Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.